Piramal Pharma is a large global healthcare company that creates and sells helpful medicines, consumer wellness items, and complex drug ingredients for patients worldwide. The trusted brand works hard to build safe medical products that help people heal faster and stay healthy. It operates modern scientific laboratories and giant manufacturing plants across multiple countries to support hospitals and local pharmacies. By focusing on smart research and high-quality standards, the enterprise delivers reliable health solutions that improve everyday living for families everywhere.
Piramal Pharma Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | ₹27,466 Cr |
| ROE | -3.58% |
| P/E Ratio (TTM) | — |
| EPS (TTM) | -2.36 |
| P/B Ratio | 3.36 |
| Dividend Yield | 0.00% |
| Industry P/E | 38.34 |
| Book Value | 61.34 |
| Debt to Equity | 0.70 |
| Face Value | 10 |
Piramal Pharma Share Price Target 2026
Piramal Pharma share price target for 2026 is expected to range from ₹170 to ₹230. Here are three key factors that could affect the company’s share price in 2026:
- Global Contract Drug Manufacturing: Piramal Pharma acts as a partner for big global pharmaceutical companies by making medicines for them. When international drug firms give the company more large manufacturing orders, overall business revenue goes up, which helps increase the share price.
- Complex Drug and Injectable Demand: The company specializes in producing complicated medicines and sterile hospital injections that are difficult to make. As global demand for these specialized medical treatments grows, the company earns higher profits, making investors happy.
- Hospital Critical Care Leadership: Selling important hospital products like inhaled anesthetics and pain relief drugs across more than one hundred countries provides steady income. Maintaining strong sales in these essential medical markets brings reliable cash flow, supporting long-term stock growth.
Piramal Pharma Share Price Target 2027
Piramal Pharma share price target for 2027 is expected to range from ₹230 to ₹290. Here are three key factors that could affect the company’s share price in 2027:
- Growing Consumer Healthcare Brands: Selling popular over-the-counter health and wellness products directly to Indian families creates a steady domestic revenue stream. When urban and rural households buy more wellness items, retail segment profits grow, strengthening the company’s overall financial health.
- Passing Strict International Quality Audits: Passing regular inspections from strict global health agencies like the US FDA proves that factory labs meet high safety standards. Clean audit reports build great trust with foreign clients, securing long-term manufacturing contracts and boosting investor confidence.
- Reducing Company Bank Loan Debt: Using business earnings and cash flows to pay down outstanding corporate debt lowers daily interest expense burdens. Lower debt levels make the business look financially secure and attractive to stock market investors.
Piramal Pharma Share Price Target 2030
Piramal Pharma share price target for 2030 is expected to range from ₹460 to ₹590. Here are three key factors that could affect the company’s share price in 2030:
- Expanding Global Facility Capacity: Investing money to upgrade factories in North America, Europe, and India allows the company to handle larger production volumes. Greater production capability lets the business accept more international orders, driving future revenue higher.
- Foreign Currency Export Earnings: Earning a large portion of its total income in strong foreign currencies like US Dollars protects the business. When foreign exchange rates turn favorable, overseas earnings increase in local value, boosting quarterly reported profits.
- New Drug Development Research: Discovering and developing new medicine formulas through joint projects with global partners opens up future income streams. Successful drug launches create exciting growth stories that attract enthusiastic buyers to the company stock.
Piramal Pharma Share Price Target 2040
Piramal Pharma share price target for 2040 is expected to range from ₹1100 to ₹1600. Here are three risks & challenges that could affect the company’s share price in 2040:
- Strict Global Regulatory Inspections: Manufacturing medicines for international markets requires following very strict rules set by foreign health regulators. If an inspector finds a factory error or safety issue, it can delay product shipments, causing sudden drops in share value.
- Client Inventory Changes and Slowdowns: Global drug companies sometimes reduce their medicine stockpiles or delay new clinical trial projects. When client orders suddenly slow down, Piramal Pharma faces unexpected revenue dips and lower quarterly profits.
- Tough International Pharmaceutical Rivalry: The global contract manufacturing industry features intense competition from large drug makers in India, China, and Western nations. If rival companies offer lower prices for making medicines, Piramal Pharma might lose profitable contracts or have to cut prices.
Piramal Pharma Share Price Target 2050
Piramal Pharma share price target for 2050 is expected to range from ₹2800 to ₹3700. Here are three risks & challenges that could affect the company’s share price in 2050:
- Foreign Currency Exchange Fluctuations: Because the company operates globally, shifting exchange rates can unpredictably reduce the value of money earned overseas. Currency swings can shrink profit margins when foreign earnings are converted back into Indian rupees.
- High Factory Running and Labour Costs: Maintaining advanced science laboratories and clean manufacturing plants requires expensive specialized equipment and skilled workers. If operational or employee expenses rise faster than sales, company profit margins shrink quickly.
- Delays in Scaling New Production Lines: Building new manufacturing blocks or launching complex medical products can take longer than expected due to technical hurdles. If factory expansion projects get delayed, money spent upfront fails to generate expected profits right away.
Piramal Pharma Share Price Target 2026 to 2050
| Year | Target Price (₹) |
|---|---|
| 2026 | 170 to 230 |
| 2027 | 230 to 290 |
| 2028 | 300 to 370 |
| 2029 | 380 to 480 |
| 2030 | 460 to 590 |
| 2040 | 1100 to 1600 |
| 2050 | 2800 to 3700 |
Also Read: Wockhardt Pharma Share Price Target
Piramal Pharma Shareholding Pattern
| Category | Holding |
|---|---|
| Public | 38.11% |
| Promoters | 34.80% |
| DII | 14.57% |
| FII | 12.52% |
Piramal Pharma Key Competitors
Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, Cipla, Lupin, Divi’s Laboratories, Biocon, Mankind Pharma, Alkem Laboratories, Torrent Pharmaceuticals, and Gland Pharma.
Disclaimer: All the information provided in this article is for educational and infomational purposes only. We are NOT a SEBI registered investment advisor. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
